Merck & Co., Inc. (SNSE:MRK)
Chile flag Chile · Delayed Price · Currency is CLP · Price in USD
102.40
0.00 (0.00%)
Last updated: Dec 16, 2025, 9:30 AM CLT

Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of CLP 227.78 trillion. The enterprise value is 248.94 trillion.

Market Cap227.78T
Enterprise Value 248.94T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Dec 15, 2025

Share Statistics

Current Share Class 2.48B
Shares Outstanding n/a
Shares Change (YoY) -0.91%
Shares Change (QoQ) -0.60%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 79.35%
Float 2.48B

Valuation Ratios

The trailing PE ratio is 12.44 and the forward PE ratio is 10.99.

PE Ratio 12.44
Forward PE 10.99
PS Ratio 3.69
PB Ratio 4.56
P/TBV Ratio 15.84
P/FCF Ratio 18.15
P/OCF Ratio 13.88
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.57, with an EV/FCF ratio of 19.84.

EV / Earnings 13.60
EV / Sales 4.25
EV / EBITDA 8.57
EV / EBIT 10.05
EV / FCF 19.84

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.80.

Current Ratio 1.66
Quick Ratio 1.09
Debt / Equity 0.80
Debt / EBITDA 1.30
Debt / FCF 3.17
Interest Coverage 21.34

Financial Efficiency

Return on equity (ROE) is 39.49% and return on invested capital (ROIC) is 19.31%.

Return on Equity (ROE) 39.49%
Return on Assets (ROA) 13.76%
Return on Invested Capital (ROIC) 19.31%
Return on Capital Employed (ROCE) 26.94%
Revenue Per Employee 834.72M
Profits Per Employee 247.34M
Employee Count75,000
Asset Turnover 0.52
Inventory Turnover 2.24

Taxes

In the past 12 months, Merck & Co. has paid 2.67 trillion in taxes.

Income Tax 2.67T
Effective Tax Rate 12.71%

Stock Price Statistics

The stock price has decreased by -20.50% in the last 52 weeks. The beta is 0.39, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y) 0.39
52-Week Price Change -20.50%
50-Day Moving Average 84.26
200-Day Moving Average 87.40
Relative Strength Index (RSI) 99.98
Average Volume (20 Days) 5

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.34

Income Statement

In the last 12 months, Merck & Co. had revenue of CLP 61.77 trillion and earned 18.30 trillion in profits. Earnings per share was 7,265.86.

Revenue61.77T
Gross Profit 48.09T
Operating Income 26.15T
Pretax Income 20.98T
Net Income 18.30T
EBITDA 30.31T
EBIT 26.15T
Earnings Per Share (EPS) 7,265.86
Full Income Statement

Balance Sheet

The company has 17.51 trillion in cash and 39.79 trillion in debt, giving a net cash position of -22,270.89 billion.

Cash & Cash Equivalents 17.51T
Total Debt 39.79T
Net Cash -22,270.89B
Net Cash Per Share n/a
Equity (Book Value) 49.91T
Book Value Per Share 20,045.23
Working Capital 18.20T
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.41 trillion and capital expenditures -3,861.83 billion, giving a free cash flow of 12.55 trillion.

Operating Cash Flow 16.41T
Capital Expenditures -3,861.83B
Free Cash Flow 12.55T
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 77.85%, with operating and profit margins of 42.33% and 29.63%.

Gross Margin 77.85%
Operating Margin 42.33%
Pretax Margin 33.96%
Profit Margin 29.63%
EBITDA Margin 49.07%
EBIT Margin 42.33%
FCF Margin 20.31%

Dividends & Yields

This stock pays an annual dividend of 3,050.72, which amounts to a dividend yield of 2,979.22%.

Dividend Per Share 3,050.72
Dividend Yield 2,979.22%
Dividend Growth (YoY) 2.90%
Years of Dividend Growth 7
Payout Ratio 41.99%
Buyback Yield 0.91%
Shareholder Yield 2,980.14%
Earnings Yield 8.04%
FCF Yield 5.51%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Merck & Co. has an Altman Z-Score of 3.89 and a Piotroski F-Score of 5.

Altman Z-Score 3.89
Piotroski F-Score 5